REG - Verici Dx PLC - Provider Participation Agreement with Prime Health

Verici DxAnnouncement

06/11/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251106:nRSF3944Ga&default-theme=true

RNS Number : 3944G  Verici Dx PLC  06 November 2025

 

Verici Dx plc

("Verici Dx" or the "Company")

 

Provider Participation Agreement with Prime Health Services

 

Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for
organ transplant, announces that it has signed a Provider Participation
Agreement ('the Agreement') with Prime Health Services ('Prime Health'), a
dynamic healthcare technology US based company focused on delivering
innovative, data-driven solutions through its Preferred Provider Organization
('PPO') network.

 

PPO networks were established to bring predictability and consistency to
pricing in healthcare. They negotiate on behalf of insurance companies to gain
discounted pricing, which benefits healthcare companies by bringing a uniform
price in reimbursement within the PPO network and fewer denials from the
insurance reimbursement. It also provides Physicians with greater confidence
in ordering as there is more certainty in the cost to their patients which in
turn provides greater cost transparency to the patient. The insurance plans
also benefit from having the PPO networks successfully negotiate this
contracted price from both a cost efficiency perspective as well as
competitive appeal.

 

Prime Health is one of the fastest-growing preferred provider networks in the
US and has more than 850,000 providers across the 50 states, processing around
35 million claims per year. Prime Health's PPO network serves a wide array of
clients, including insurance carriers, third-party administrators,
self-insured organisations, government entities, and captive insurance groups
which provides significant opportunity for Verici Dx to expand its patient
scope.

 

Patti Connolly, Chief Operating Officer at Verici Dx, said: "This agreement
with Prime Health is an important milestone for Verici Dx, as we accelerate
our commercial reach, expanding our patient network and supporting our
approach to increased coverage from private payors. We look forward to
updating shareholders on additional agreements of this nature in due course."

 

 

 Verici Dx plc                                 www.vericidx.com (https://vericidx.com/)

 Sara Barrington, CEO                          Via Walbrook PR

 Singer Capital Markets (Nominated adviser, Joint Broker)                     Tel: +44 (0)20 7496 3000
 Phil Davies / Sam Butcher

 Oberon Capital (Joint Broker)                 Tel: +44 (0)20 3179 0500
 Mike Seabrook

 Walbrook PR (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or vericidx@walbrookpr.com
 Alice Woodings / Paul McManus                 Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGRFSEESIEISELF



            Copyright 2019 Regulatory News Service, all rights reserved